These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10357176)

  • 1. Extracellular reduction of Cat1 free radical by transformed human hepatocytes.
    Bernas T; Dobrucki J
    Biosci Rep; 1998 Dec; 18(6):341-50. PubMed ID: 10357176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of a tetrazolium salt, CTC, by intact HepG2 human hepatoma cells: subcellular localisation of reducing systems.
    Bernas T; Dobrucki J
    Biochim Biophys Acta; 1999 Aug; 1451(1):73-81. PubMed ID: 10446389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of plasma membrane in bioreduction of two tetrazolium salts, MTT, and CTC.
    Bernas T; Dobrucki JW
    Arch Biochem Biophys; 2000 Aug; 380(1):108-16. PubMed ID: 10900139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butein imparts free radical scavenging, anti-oxidative and proapoptotic properties in the flower extracts of Butea monosperma.
    Sehrawat A; Kumar V
    Biocell; 2012 Aug; 36(2):63-71. PubMed ID: 23185781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species-specific differences in peroxisome proliferation, catalase, and SOD2 upregulation as well as toxicity in human, mouse, and rat hepatoma cells induced by the explosive and environmental pollutant 2,4,6-trinitrotoluene.
    Naumenko EA; Ahlemeyer B; Baumgart-Vogt E
    Environ Toxicol; 2017 Mar; 32(3):989-1006. PubMed ID: 27322098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Cyano-2,3-ditolyl tetrazolium chloride (CTC) reduction in a mesophilic anaerobic digester: measuring redox behavior, differentiating abiotic reduction, and comparing FISH response as an activity indicator.
    Gruden CL; Fevig S; Abu-Dalo M; Hernandez M
    J Microbiol Methods; 2003 Jan; 52(1):59-68. PubMed ID: 12401227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-surface NAD(P)H-oxidase: relationship to trans-plasma membrane NADH-oxidoreductase and a potential source of circulating NADH-oxidase.
    Berridge MV; Tan AS
    Antioxid Redox Signal; 2000; 2(2):277-88. PubMed ID: 11229532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
    Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of intracellular glutathione in controlling ascorbic acid transporter expression and function in rat hepatocytes and hepatoma cells.
    Mardones L; Zúñiga FA; Villagrán M; Sotomayor K; Mendoza P; Escobar D; González M; Ormazabal V; Maldonado M; Oñate G; Angulo C; Concha II; Reyes AM; Cárcamo JG; Barra V; Vera JC; Rivas CI
    Free Radic Biol Med; 2012 May; 52(9):1874-87. PubMed ID: 22348976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ascorbic acid and sodium selenite on growth and redifferentiation in human hepatoma cells and its mechanisms.
    Zheng QS; Zheng RL
    Pharmazie; 2002 Apr; 57(4):265-9. PubMed ID: 11998448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSC 74859-mediated inhibition of STAT3 enhances the anti-proliferative activity of cetuximab in hepatocellular carcinoma.
    Chen W; Shen X; Xia X; Xu G; Ma T; Bai X; Liang T
    Liver Int; 2012 Jan; 32(1):70-7. PubMed ID: 22098470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.
    Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H
    Oncology; 2004; 66(6):481-91. PubMed ID: 15452378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation.
    El Boustany C; Bidaux G; Enfissi A; Delcourt P; Prevarskaya N; Capiod T
    Hepatology; 2008 Jun; 47(6):2068-77. PubMed ID: 18506892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of exendin-4-induced steatosis by protein kinase A in cultured HepG2 human hepatoma cells.
    Chen-Liaw AY; Hammel G; Gomez G
    In Vitro Cell Dev Biol Anim; 2017 Sep; 53(8):721-727. PubMed ID: 28707223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-matrix talks: effects on differentiation of hepatocellular carcinoma.
    Wu XZ; Chen D
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):407-13. PubMed ID: 17108870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel human hepatoma cell line, FLC-4, exhibits highly enhanced liver differentiation functions through the three-dimensional cell shape.
    Laurent T; Murase D; Tsukioka S; Matsuura T; Nagamori S; Oda H
    J Cell Physiol; 2012 Jul; 227(7):2898-906. PubMed ID: 21960466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells.
    Simbula G; Columbano A; Ledda-Columbano GM; Sanna L; Deidda M; Diana A; Pibiri M
    Apoptosis; 2007 Jan; 12(1):113-23. PubMed ID: 17136495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor.
    Yang L; Liu X; Lu Z; Yuet-Wa Chan J; Zhou L; Fung KP; Wu P; Wu S
    Cancer Lett; 2010 Dec; 298(1):128-38. PubMed ID: 20630652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diindolylmethane on Ca(2+) movement and viability in HA59T human hepatoma cells.
    Cheng JS; Shu SS; Kuo CC; Chou CT; Tsai WL; Fang YC; Kuo LN; Yeh JH; Chen WC; Chien JM; Lu T; Pan CC; Cheng HH; Chai KL; Jan CR
    Arch Toxicol; 2011 Oct; 85(10):1257-66. PubMed ID: 21409406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.
    Cao L; Xie B; Yang X; Liang H; Jiang X; Zhang D; Xue P; Chen D; Shao Z
    PLoS One; 2015; 10(7):e0133074. PubMed ID: 26177288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.